Talía Malagón

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Topics

Systematic Review

Squamous Cell Carcinoma

Cervical Cancer Screening

Fine Needle Aspiration

Top Venues

International journal of cancer

Nature reviews. Clinical oncology

Journal of the National Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Publications

Talía Malagón, Eduardo L Franco, Romina Tejada, Salvatore Vaccarella
Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination. Nature reviews. Clinical oncology 21 (7) (2024)
Joachim Worthington, Zhuolu Sun, Rui Fu, Jie-Bin Lew, Kelvin K W Chan, Qing Li, Antoine Eskander, Harriet Hui, Kirstie McLoughlin, Michael Caruana, Stuart Peacock, Jean Hai Ein Yong, Karen Canfell, Eleonora Feletto, Talía Malagón
COVID-related disruptions to colorectal cancer screening, diagnosis, and treatment could increase cancer Burden in Australia and Canada: A modelling study. PloS one 19 (4) (2024)
Talía Malagón, Eduardo L Franco, Romina Tejada, Salvatore Vaccarella
Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination. Nature reviews. Clinical oncology (2024)
Joachim Worthington, Zhuolu Sun, Rui Fu, Jie-Bin Lew, Kelvin K W Chan, Qing Li, Antoine Eskander, Harriet Hui, Kirstie McLoughlin, Michael Caruana, Stuart Peacock, Jean Hai Ein Yong, Karen Canfell, Eleonora Feletto, Talía Malagón
COVID-related disruptions to colorectal cancer screening, diagnosis, and treatment could increase cancer Burden in Australia and Canada: A modelling study. PloS one 19 (4) (2024)
Talía Malagón
Time to change the paradigm for primary endpoints in cancer screening trials? Journal of the National Cancer Institute (2024)
Talía Malagón, Eduardo L Franco, Romina Tejada, Salvatore Vaccarella
Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination. Nature reviews. Clinical oncology (2024)
Talía Malagón
Time to change the paradigm for primary endpoints in cancer screening trials? Journal of the National Cancer Institute 116 (8) (2024)
Parker Tope, Samantha Morais, Eduardo L Franco, Eduardo L Franco, Talía Malagón
Differences in site-specific cancer incidence by individual- and area-level income in Canada from 2006 to 2015. International journal of cancer (2023)
Talía Malagón, Helen Trottier, Eduardo L Franco, Luisa L Villa, Eduardo L Franco, null null
Human papillomavirus intermittence and risk factors associated with first detections and redetections in the Ludwig-McGill cohort study of adult women. The Journal of infectious diseases (2023)
Talía Malagón, Aline Lopes Ribeiro, Emily Montosa Nunes, Tarik Gheit, Eduardo L Franco, Luisa Lina Villa, Eduardo L Franco, Laura Sichero
Betapapillomavirus natural history and co-detection with alphapapillomavirus in cervical samples of adult women. Journal of medical virology 95 (12) (2023)
Talía Malagón, Samantha Morais, Parker Tope, Eduardo L Franco, Eduardo L Franco
Site-specific cancer incidence by race and immigration status in Canada 2006-2015: a population-based data linkage study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Talía Malagón, Aaron MacCosham, Ann N Burchell, Mariam El-Zein, Pierre-Paul Tellier, François Coutlée, Eduardo L Franco, null null
Proportion of incident genital human papillomavirus detections not attributable to transmission and potentially attributable to latent infections: Implications for cervical cancer screening. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Talía Malagón, Jean H E Yong, Parker Tope, Wilson H Miller, Eduardo L Franco, null null
Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada. International journal of cancer (2021)
Talía Malagón, Karena D Volesky, Eduardo L Franco
Reply to: Comments on cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis. International journal of cancer 148 (11) (2021)
Talía Malagón, Marie-Helene Mayrand, Gina Ogilvie, Walter H Gotlieb, Jennifer Blake, Céline Bouchard, Eduardo L Franco, Shalini Kulasingam
Modeling the Balance of Benefits and Harms of Cervical Cancer Screening with Cytology and Human Papillomavirus Testing. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29 (7) (2020)
Talía Malagón, Karena D Volesky, Sheila Bouten, Claudie Laprise, Eduardo L Franco, Eduardo L Franco
Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis. International journal of cancer 147 (10) (2020)
Talía Malagón, Cassandra Laurie, Eduardo L Franco
Human papillomavirus vaccination and the role of herd effects in future cancer control planning: a review. Expert review of vaccines 17 (5) (2018)